dc.contributor.author | Yelland, Michael | |
dc.date.accessioned | 2021-07-21T06:18:21Z | |
dc.date.available | 2021-07-21T06:18:21Z | |
dc.date.issued | 2017 | |
dc.identifier.issn | 0003-4819 | |
dc.identifier.doi | 10.7326/ACPJC-2017-166-2-002 | |
dc.identifier.uri | http://hdl.handle.net/10072/406199 | |
dc.language | English | |
dc.publisher | American College of Physicians | |
dc.relation.ispartofpagefrom | JC2 | |
dc.relation.ispartofissue | 2 | |
dc.relation.ispartofjournal | Annals of Internal Medicine | |
dc.relation.ispartofvolume | 166 | |
dc.subject.fieldofresearch | Biomedical and clinical sciences | |
dc.subject.fieldofresearchcode | 32 | |
dc.subject.keywords | Science & Technology | |
dc.subject.keywords | Life Sciences & Biomedicine | |
dc.subject.keywords | Medicine, General & Internal | |
dc.subject.keywords | General & Internal Medicine | |
dc.subject.keywords | DULOXETINE | |
dc.title | Pregabalin reduces fibromyalgia pain but increases adverse events (Review) | |
dc.type | Journal article | |
dc.type.description | C2 - Articles (Other) | |
dcterms.bibliographicCitation | Yelland, M, Pregabalin reduces fibromyalgia pain but increases adverse events (Review), Annals of Internal Medicine, 2017, 166 (2), pp. JC2 | |
dc.date.updated | 2021-07-21T06:15:38Z | |
gro.hasfulltext | No Full Text | |
gro.griffith.author | Yelland, Michael | |